| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | 470.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-22 | n/a | (6.27) | (5.60)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-23 | 5.27 | (14.30) | (15.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-24 | n/a | (9.12) | (6.80)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-25 | 4.71 | (15.30) | (12.60)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-26 | n/a | (20.23) | (17.30)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Notice of AGM | 23-Oct-2026 | 07:00 | RNS |
| Result of General Meeting | 20-Oct-2026 | 12:28 | RNS |
| Issue of Equity, Director Dealing & Voting Rights | 15-Oct-2026 | 07:00 | RNS |
| /C O R R E C T I O N -- KushoAI/ | 02-Apr-2026 | ShareCast |
| FDA clears Scancell's application for phase thre... | 26-Jan-2026 | ShareCast |
| Scancell reports further data from DNA cancer im... | 09-Dec-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 80.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 265.00 |
| 52 Week Low | 79.00 |
| Volume | 2,041,146 |
| Shares Issued | 121.22m |
| Market Cap | £96.98m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:37 | 35,000 @ 79.10p |
| 13:36 | 560,000 @ 79.66p |
| 13:38 | 90,000 @ 79.66p |
| 11:11 | 100,000 @ 80.00p |
| 13:35 | 100,000 @ 80.00p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research